Eric Alejandro Miller Form 3 ACADIA PHARMACEUTICALS / Eric Alejandro Miller ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Miller Eric Alejandro

(Last) (First) (Middle)

C/O ACADIA PHARMACEUTICALS INC.

3611 VALLEY CENTRE DRIVE, SUITE 300

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/02/2018

3. Issuer Name and Ticker or Trading Symbol
ACADIA PHARMACEUTICALS INC [ ACAD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Controller & PAO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,212	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(1)	05/29/2024	Common Stock	7,500	20.65	D
Employee Stock Option (Right to Buy)	(2)	01/25/2025	Common Stock	3,900	32.28	D
Employee Stock Option (Right to Buy)	(3)	01/05/2026	Common Stock	6,615	29.24	D
Employee Stock Option (Right to Buy)	(4)	03/07/2027	Common Stock	7,350	36.54	D
Employee Stock Option (Right to Buy)	(5)	09/06/2027	Common Stock	9,187	35.8	D
Employee Stock Option (Right to Buy)	(6)	04/06/2028	Common Stock	5,570	16.5	D
Employee Stock Option (Right to Buy)	(7)	10/14/2028	Common Stock	3,342	21.28	D
Restricted Stock Units	(8)	(8)	Common Stock	1,671	(9)	D

Explanation of Responses:

1. This option is fully vested and exercisable.

2. 25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2016, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

3. 25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2017, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

4. 25% of the shares subject to the Stock Option vested and became exercisable on March 8, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

5. 25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

6. 25% of the shares subject to the Stock Option vest and become exercisable on April 7, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

7. 25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

8. The restricted stock units vest in four equal annual installments beginning October 15, 2019.

9. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

	/s/ Eric Alejandro Miller	11/09/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.